Cosmo Pharmaceuticals reports record results for 2022, preliminary results exceeding guidance, increased dividend distribution and 2023 guidance
Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced its preliminary unaudited results for the financial year 2022.